Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2015-2025
- HEY3758689
- 87 Pages
- February 2020
- Healthcare
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Pharmacy
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Picture
1.1.2 Specifications
Table Product Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Type, 2011-2022 (USD Million)
1.2.1.1 Exenatied
Table Exenatied Overview
1.2.1.2 Liraglutide
Table Liraglutide Overview
1.2.1.3 Lixisenatide
Table Lixisenatide Overview
1.2.1.4 Albiglutide
Table Albiglutide Overview
1.2.1.5 Dulaglutide
Table Dulaglutide Overview
1.2.2 by Application
Table Application Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Application, 2011-2022 (USD Million)
1.2.2.1 Hospital
Table Hospital Overview
1.2.2.2 Pharmacy
Table Pharmacy Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
2.2 Upstream
Table Cost of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Manufacturing Process of Glucagon Like Peptide-1 (GLP-1) Agonists
2.3 Market
2.3.1 SWOT
Figure SWOT of Glucagon Like Peptide-1 (GLP-1) Agonists
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Glucagon Like Peptide-1 (GLP-1) Agonists
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Glucagon Like Peptide-1 (GLP-1) Agonists
3.4 Market Entry
Table Market Entry of Glucagon Like Peptide-1 (GLP-1) Agonists
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Exenatied Market, 2013-2018
Figure Exenatied Market Size and Growth, 2012-2018 (USD Million)
Figure Exenatied Market Size and Growth, 2012-2018 (in Volume)
Table Exenatied CAGR by Revenue and Volume, 2012-2018
4.1.2 Liraglutide Market, 2013-2018
Figure Liraglutide Market Size and Growth, 2012-2018 (USD Million)
Figure Liraglutide Market Size and Growth, 2012-2018 (in Volume)
Table Liraglutide CAGR by Revenue and Volume, 2012-2018
4.1.3 Lixisenatide Market, 2013-2018
Figure Lixisenatide Market Size and Growth, 2012-2018 (USD Million)
Figure Lixisenatide Market Size and Growth, 2012-2018 (in Volume)
Table Lixisenatide CAGR by Revenue and Volume, 2012-2018
4.1.4 Albiglutide Market, 2013-2018
Figure Albiglutide Market Size and Growth, 2012-2018 (USD Million)
Figure Albiglutide Market Size and Growth, 2012-2018 (in Volume)
Table Albiglutide CAGR by Revenue and Volume, 2012-2018
4.1.5 Dulaglutide Market, 2013-2018
Figure Dulaglutide Market Size and Growth, 2012-2018 (USD Million)
Figure Dulaglutide Market Size and Growth, 2012-2018 (in Volume)
Table Dulaglutide CAGR by Revenue and Volume, 2012-2018
4.2 Market Forecast
4.2.1 Exenatied Market Forecast, 2020-2025
Figure Exenatied Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Exenatied Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Exenatied CAGR by Revenue and Volume, 2012-2024
4.2.2 Liraglutide Market Forecast, 2020-2025
Figure Liraglutide Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Liraglutide Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Liraglutide CAGR by Revenue and Volume, 2012-2024
4.2.3 Lixisenatide Market Forecast, 2020-2025
Figure Lixisenatide Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Lixisenatide Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Lixisenatide CAGR by Revenue and Volume, 2012-2024
4.2.4 Albiglutide Market Forecast, 2020-2025
Figure Albiglutide Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Albiglutide Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Albiglutide CAGR by Revenue and Volume, 2012-2024
4.2.5 Dulaglutide Market Forecast, 2020-2025
Figure Dulaglutide Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Dulaglutide Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Dulaglutide CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2013-2018
Figure Hospital Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2012-2018
5.1.2 Pharmacy Market, 2013-2018
Figure Pharmacy Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Pharmacy CAGR by Revenue and Volume, 2012-2018
5.1.3 Others Market, 2013-2018
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2018
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2020-2025
Figure Hospital Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2020-2025
5.2.2 Pharmacy Market Forecast, 2020-2025
Figure Pharmacy Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Pharmacy Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Pharmacy CAGR by Revenue and Volume, 2020-2025
5.2.3 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Table North America CAGR by Revenue and Volume, 2012-2018
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Table Europe CAGR by Revenue and Volume, 2012-2018
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Table South America CAGR by Revenue and Volume, 2012-2018
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Vendors, 2012-2018 (in Volume)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Vendors, 2012-2018 (USD Million)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Vendors, 2012-2018 (in Volume)
7.2 Market Concentration
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Novo Nordisk
Table Novo Nordisk Profile List
Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 AstraZeneca
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Eli Lily
Table Eli Lily Profile List
Table Microecological Modulator Operating Data of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 GSK
Table GSK Profile List
Table Microecological Modulator Operating Data of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Sanofi
Table Sanofi Profile List
Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Bristol-Myers Squibb
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Amylin
Table Amylin Profile List
Table Microecological Modulator Operating Data of Amylin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Products Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Type, 2011-2022 (USD Million)
Table Exenatied Overview
Table Liraglutide Overview
Table Lixisenatide Overview
Table Albiglutide Overview
Table Dulaglutide Overview
Table Application Segment of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Application, 2011-2022 (USD Million)
Table Hospital Overview
Table Pharmacy Overview
Table Others Overview
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region, 2011-2022 (USD Million)
Table Cost of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Market Dynamics
Table Policy of Glucagon Like Peptide-1 (GLP-1) Agonists
Table GDP of Major Countries
Table Technology of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Market Entry of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Exenatied CAGR by Revenue and Volume, 2012-2018
Table Liraglutide CAGR by Revenue and Volume, 2012-2018
Table Lixisenatide CAGR by Revenue and Volume, 2012-2018
Table Albiglutide CAGR by Revenue and Volume, 2012-2018
Table Dulaglutide CAGR by Revenue and Volume, 2012-2018
Table Exenatied CAGR by Revenue and Volume, 2012-2024
Table Liraglutide CAGR by Revenue and Volume, 2012-2024
Table Lixisenatide CAGR by Revenue and Volume, 2012-2024
Table Albiglutide CAGR by Revenue and Volume, 2012-2024
Table Dulaglutide CAGR by Revenue and Volume, 2012-2024
Table Hospital CAGR by Revenue and Volume, 2012-2018
Table Pharmacy CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Hospital CAGR by Revenue and Volume, 2020-2025
Table Pharmacy CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
Table North America CAGR by Revenue and Volume, 2012-2018
Table Europe CAGR by Revenue and Volume, 2012-2018
Table South America CAGR by Revenue and Volume, 2012-2018
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market by Vendors, 2012-2018 (in Volume)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Vendors, 2012-2018 (USD Million)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Novo Nordisk Profile List
Table Microecological Modulator Operating Data of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lily Profile List
Table Microecological Modulator Operating Data of Eli Lily (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Profile List
Table Microecological Modulator Operating Data of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Profile List
Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amylin Profile List
Table Microecological Modulator Operating Data of Amylin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
